SCOPUS 정보 검색 플랫폼

Clinical and Experimental Metastasis

Volumn 26, Issue 7, 2009, Pages 625-632

Metastatic gene signatures and emerging novel prognostic tests in the management of early stage breast cancer

(3) Tordai, Attila a,b Liedtke, Cornelia a,c Pusztai, Lajos a

a UNIVERSITY OF TEXAS (United States)

b National Hematology Institute (Hungary)

c UNIVERSITY OF MÜNSTER (Germany)

Author keywords

Breast cancer; Gene signatures; Genomics

Indexed keywords

MESSENGER RNA;

BREAST CANCER; CANCER GENETICS; CANCER STAGING; DNA MICROARRAY; GENE EXPRESSION PROFILING; METASTASIS; PROGNOSIS; REVIEW; RNA TRANSCRIPTION;

BREAST NEOPLASMS; EARLY DIAGNOSIS; GENE EXPRESSION PROFILING; HUMANS; NEOPLASM METASTASIS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PROGNOSIS;

EID: 71849087219 PISSN: 02620898 EISSN: 15737276 Source Type: Journal
DOI: 10.1007/s10585-009-9261-z Document Type: Review

Times cited : (2)

References (18)

1
- 0003737578
- A.G. Carmichael R.M. Ratzan (eds). Beaux Arts Editions New York
- Carmichael AG, Ratzan RM (eds) (2001) Medicine, a treasury of art and literature. Beaux Arts Editions, New York, p 29
- (2001) Medicine, a Treasury of Art and Literature , pp. 29

2
- 0031941706
- Survey of breast cancer patients concerning their knowledge and expectations of adjuvant therapy
- 1:STN:280:DyaK1c7ivFagtQ%3D%3D 9469335
- PM Ravdin IA Siminoff JA Harvey, et al. 1998 Survey of breast cancer patients concerning their knowledge and expectations of adjuvant therapy J Clin Oncol 16 515 521 1:STN:280:DyaK1c7ivFagtQ%3D%3D 9469335
- (1998) J Clin Oncol , vol.16 , pp. 515-521
- Ravdin, P.M.¹ Siminoff, I.A.² Harvey, J.A.³

3
- 18444383684
- Population-based validation of the prognostic model ADJUVANT! for early breast cancer
- DOI 10.1200/JCO.2005.06.178
- IA Olivotto CD Bajdik PM Ravdin, et al. 2005 Population-based validation of the prognostic model ADJUVANT! for early breast cancer J Clin Oncol 23 2716 2725 10.1200/JCO.2005.06.178 10.1200/JCO.2005.06.178 15837986 (Pubitemid 46179461)
- (2005) Journal of Clinical Oncology , vol.23 , Issue.12 , pp. 2716-2725
- Olivotto, I.A.¹ Bajdik, C.D.² Ravdin, P.M.³ Speers, C.H.⁴ Coldman, A.J.⁵ Norris, B.D.⁶ Davis, G.J.⁷ Chia, S.K.⁸ Gelmon, K.A.⁹

4
- 33846223871
- Chips to bedside: Incorporation of microarray data into clinical practice
- DOI 10.1158/1078-0432.CCR-06-2649
- L Pusztai 2006 Chips to bedside: incorporation of microarray data into clinical practice Clin Cancer Res 12 7209 7214 10.1158/1078-0432.CCR-06-2649 10.1158/1078-0432.CCR-06-2649 1:CAS:528:DC%2BD28XhtlCrsbfK 17189391 (Pubitemid 46095390)
- (2006) Clinical Cancer Research , vol.12 , Issue.24 , pp. 7209-7214
- Pusztai, L.¹

5
- 0037137519
- A gene-expression signature as a predictor of survival in breast cancer
- DOI 10.1056/NEJMoa021967
- MJ Van de Vijver DH Yudong 2002 A gene-expression signature as a predictor of survival in breast cancer N Engl J Med 347 1999 2009 10.1056/NEJMoa021967 10.1056/NEJMoa021967 12490681 (Pubitemid 35461656)
- (2002) New England Journal of Medicine , vol.347 , Issue.25 , pp. 1999-2009
- Van De Vijver, M.J.¹ He, Y.D.² Van 'T Veer, L.J.³ Dai, H.⁴ Hart, A.A.M.⁵ Voskuil, D.W.⁶ Schreiber, G.J.⁷ Peterse, J.L.⁸ Roberts, C.⁹ Marton, M.J.¹⁰ Parrish, M.¹¹ Atsma, D.¹² Witteveen, A.¹³ Glas, A.¹⁴ Delahaye, L.¹⁵ Van Der Velde, T.¹⁶ Bartelink, H.¹⁷ Rodenhuis, S.¹⁸ Rutgers, E.T.¹⁹ Friend, S.H.²⁰ Bernards, R.²¹ more..

6
- 33748693297
- Validation and clinical utility of a 70-gene prognostic signature for women with node-negative breast cancer
- 1:CAS:528:DC%2BD28Xps1yjtLw%3D 16954471
- M Buyse S Loi L van't Veer, et al. 2006 Validation and clinical utility of a 70-gene prognostic signature for women with node-negative breast cancer J Natl Cancer Inst 98 1183 1192 1:CAS:528:DC%2BD28Xps1yjtLw%3D 16954471
- (2006) J Natl Cancer Inst , vol.98 , pp. 1183-1192
- Buyse, M.¹ Loi, S.² Van'T Veer, L.³

7
- 33645825388
- Multicenter validation of a gene expression-based prognostic signature in lymph node-negative primary breast cancer
- DOI 10.1200/JCO.2005.03.9115
- JA Foekens D Atkins Y Zhang, et al. 2006 Multicenter validation of a gene expression-based prognostic signature in lymph node-negative primary breast cancer J Clin Oncol 24 1665 1671 10.1200/JCO.2005.03.9115 10.1200/JCO.2005.03. 9115 1:CAS:528:DC%2BD28XksVKgtLo%3D 16505412 (Pubitemid 46622137)
- (2006) Journal of Clinical Oncology , vol.24 , Issue.11 , pp. 1665-1671
- Foekens, J.A.¹ Atkins, D.² Zhang, Y.³ Sweep, F.C.G.J.⁴ Harbeck, N.⁵ Paradiso, A.⁶ Cufer, T.⁷ Sieuwerts, A.M.⁸ Talantov, D.⁹ Span, P.N.¹⁰ Tjan-Heijnen, V.C.G.¹¹ Zito, A.F.¹² Specht, K.¹³ Hoefler, H.¹⁴ Golouh, R.¹⁵ Schittulli, F.¹⁶ Schmitt, M.¹⁷ Beex, L.V.A.M.¹⁸ Klijn, J.G.M.¹⁹ Wang, Y.²⁰ more..

8
- 34250652449
- Strong time dependence of the 76-gene prognostic signature for node-negative breast cancer patients in the TRANSBIG multicenter independent validation series
- DOI 10.1158/1078-0432.CCR-06-2765
- C Desmedt F Piette S Loi, et al. 2007 Strong time dependence of the 76-gene prognostic signature for node-negative breast cancer patients in the TRANSBIG multicenter independent validation series Clin Cancer Res 13 3207 3214 10.1158/1078-0432.CCR-06-2765 10.1158/1078-0432.CCR-06-2765 1:CAS:528: DC%2BD2sXmtVajur0%3D 17545524 (Pubitemid 46944903)
- (2007) Clinical Cancer Research , vol.13 , Issue.11 , pp. 3207-3214
- Desmedt, C.¹ Piette, F.² Loi, S.³ Wang, Y.⁴ Lallemand, F.⁵ Haibe-Kains, B.⁶ Viale, G.⁷ Delorenzi, M.⁸ Zhang, Y.⁹ D'Assignies, M.S.¹⁰ Bergh, J.¹¹ Lidereau, R.¹² Ellis, P.¹³ Harris, A.L.¹⁴ Klijn, J.G.M.¹⁵ Foekens, J.A.¹⁶ Cardoso, F.¹⁷ Piccart, M.J.¹⁸ Buyse, M.¹⁹ Sotiriou, C.²⁰ more..

9
- 19944422061
- A multigene assay to predict recurrence of tamoxifen-treated, node-negative breast cancer
- 10.1056/NEJMoa041588 10.1056/NEJMoa041588
- S Paik S Shak G Tang, et al. 2006 A multigene assay to predict recurrence of tamoxifen-treated, node-negative breast cancer N Engl J Med 351 2817 2826 10.1056/NEJMoa041588 10.1056/NEJMoa041588
- (2006) N Engl J Med , vol.351 , pp. 2817-2826
- Paik, S.¹ Shak, S.² Tang, G.³

10
- 33744808550
- A population-based study of tumor gene expression and risk of breast cancer death among lymp node-negative patients
- DOI 10.1186/bcr1412
- LA Habel S Shak MK Jacobs, et al. 2006 A population-based study of tumor gene expression and risk of breast cancer death among lymph node-negative patients Breast Cancer Res 8 R25 10.1186/bcr1412 10.1186/bcr1412 16737553 (Pubitemid 43827376)
- (2006) Breast Cancer Research , vol.8 , Issue.3
- Habel, L.A.¹ Shak, S.² Jacobs, M.K.³ Capra, A.⁴ Alexander, C.⁵ Pho, M.⁶ Baker, J.⁷ Walker, M.⁸ Watson, D.⁹ Hackett, J.¹⁰ Blick, N.T.¹¹ Greenberg, D.¹² Fehrenbacher, L.¹³ Langholz, B.¹⁴ Quesenberry, C.P.¹⁵

11
- 33744814477
- Gene expression and benefit of chemotherapy in women with node-negative, estrogen receptor-positive breast cancer
- DOI 10.1200/JCO.2005.04.7985
- S Paik G Tang S Shak, et al. 2006 Gene expression and benefit of chemotherapy in women with node-negative, estrogen receptor-positive breast cancer J Clin Oncol 24 3726 3734 10.1200/JCO.2005.04.7985 10.1200/JCO.2005.04. 7985 1:CAS:528:DC%2BD28XpsVaqsrs%3D 16720680 (Pubitemid 46622311)
- (2006) Journal of Clinical Oncology , vol.24 , Issue.23 , pp. 3726-3734
- Paik, S.¹ Tang, G.² Shak, S.³ Kim, C.⁴ Baker, J.⁵ Kim, W.⁶ Cronin, M.⁷ Baehner, F.L.⁸ Watson, D.⁹ Bryant, J.¹⁰ Costantino, J.P.¹¹ Geyer Jr., C.E.¹² Wickerham, D.L.¹³ Wolmark, N.¹⁴

12
- 52949151008
- Prognostic utility of the 21-gene assay in hormone receptor (HR) positive operable breast cancer and 0-3 positive axillary nodes treated with adjuvant chemo-hormonal therapy: An analysis of Intergoup trial E2197
- (Abst 526)
- Goldstein LJ, Gray R, Childs B et al. (2007) Prognostic utility of the 21-gene assay in hormone receptor (HR) positive operable breast cancer and 0-3 positive axillary nodes treated with adjuvant chemo-hormonal therapy: an analysis of Intergoup trial E2197. Proc Am Soc Clin Oncol (Abst 526)
- (2007) Proc Am Soc Clin Oncol
- Goldstein, L.J.¹ Gray, R.² Childs, B.³

13
- 71849109778
- A genomic index of estrogen receptor reporter genes predicts benefit from adjuvant endocrine therapy independent of baseline prognosis
- (Abst 1027)
- WF Symmans C Hatzis C Sotiriou, et al. 2006 A genomic index of estrogen receptor reporter genes predicts benefit from adjuvant endocrine therapy independent of baseline prognosis Breast Cancer Res Treat 100 S47 (Abst 1027)
- (2006) Breast Cancer Res Treat , vol.100 , pp. 47
- Symmans, W.F.¹ Hatzis, C.² Sotiriou, C.³

14
- 33746006844
- Novel prognostic immunohistochemical biomarker panel for estrogen receptor-positive breast cancer
- DOI 10.1200/JCO.2006.05.6564
- BZ Ring RS Seitz R Beck, et al. 2006 Novel prognostic immunohistochemical biomarker panel for estrogen receptor-positive breast cancer J Clin Oncol 24 3039 3047 10.1200/JCO.2006.05.6564 10.1200/JCO.2006.05.6564 1:CAS:528: DC%2BD28XnslKhsrc%3D 16809728 (Pubitemid 46638938)
- (2006) Journal of Clinical Oncology , vol.24 , Issue.19 , pp. 3039-3047
- Ring, B.Z.¹ Seitz, R.S.² Beck, R.³ Shasteen, W.J.⁴ Tarr, S.M.⁵ Cheang, M.C.U.⁶ Yoder, B.J.⁷ Budd, G.T.⁸ Nielsen, T.O.⁹ Hicks, D.G.¹⁰ Estopinal, N.C.¹¹ Ross, D.T.¹²

15
- 33644663354
- Nomograms to predict pathologic complete response and metastasis-free survival after preoperative chemotherapy for breast cancer
- DOI 10.1200/JCO.2005.01.2898
- R Rouzier L Pusztai S Delaloge, et al. 2005 Nomograms to predict pathologic complete response and metastasis-free survival after preoperative chemotherapy for breast cancer J Clin Oncol 23 8331 8339 10.1200/JCO.2005.01. 2898 10.1200/JCO.2005.01.2898 16293864 (Pubitemid 46260228)
- (2005) Journal of Clinical Oncology , vol.23 , Issue.33 , pp. 8331-8339
- Rouzier, R.¹ Pusztai, L.² Delaloge, S.³ Gonzalez-Angulo, A.M.⁴ Andre, F.⁵ Hess, K.R.⁶ Buzdar, A.U.⁷ Garbay, J.-R.⁸ Spielmann, M.⁹ Mathieu, M.-C.¹⁰ Symmans, W.F.¹¹ Wagner, P.¹² Atallah, D.¹³ Valero, V.¹⁴ Berry, D.A.¹⁵ Hortobagyi, G.N.¹⁶

16
- 20444451252
- Technology insight: Emerging techniques to predict response to preoperative chemotherapy in breast cancer
- DOI 10.1038/ncponc0025
- L Pusztai L Gianni 2004 Prediction of response to preoperative chemotherapy in operable breast cancer Nat Clin Pract Oncol 1 44 50 10.1038/ncponc0025 10.1038/ncponc0025 16264799 (Pubitemid 40812648)
- (2004) Nature Clinical Practice Oncology , vol.1 , Issue.1 , pp. 44-50
- Pusztai, L.¹ Gianni, L.²

17
- 33749030177
- Pharmacogenomic predictor of sensitivity to preoperative chemotherapy with paclitaxel and fluorouracil, doxorubicin, and cyclophosphamide in breast cancer
- DOI 10.1200/JCO.2006.05.6861
- KR Hess K Anderson W Symmans, et al. 2006 Pharmacogenomic predictor of sensitivity to preoperative chemotherapy with paclitaxel and fluorouracil, doxorubicin, and cyclophosphamide in breast cancer J Clin Oncol 24 4236 4244 10.1200/JCO.2006.05.6861 10.1200/JCO.2006.05.6861 1:CAS:528:DC%2BD28XhtVGju7vJ 16896004 (Pubitemid 46630780)
- (2006) Journal of Clinical Oncology , vol.24 , Issue.26 , pp. 4236-4244
- Hess, K.R.¹ Anderson, K.² Symmans, W.F.³ Valero, V.⁴ Ibrahim, N.⁵ Mejia, J.A.⁶ Booser, D.⁷ Theriault, R.L.⁸ Buzdar, A.U.⁹ Dempsey, P.J.¹⁰ Rouzier, R.¹¹ Sneige, N.¹² Ross, J.S.¹³ Vidaurre, T.¹⁴ Gomez, H.L.¹⁵ Hortobagyi, G.N.¹⁶ Pusztai, L.¹⁷

18
- 33847111335
- Determination of oestrogen-receptor status and ERBB2 status of breast carcinoma: a gene-expression profiling study
- DOI 10.1016/S1470-2045(07)70042-6, PII S1470204507700426
- Y Gong K Yan F Lin, et al. 2007 Determination of oestrogen-receptor status and ERBBS status of breast carcinoma: a gene-expression profiling study Lancet Oncol 8 203 211 10.1016/S1470-2045(07)70042-6 10.1016/S1470-2045(07) 70042-6 1:CAS:528:DC%2BD2sXisVCqsrY%3D 17329190 (Pubitemid 46304454)
- (2007) Lancet Oncology , vol.8 , Issue.3 , pp. 203-211
- Gong, Y.¹ Yan, K.² Lin, F.³ Anderson, K.⁴ Sotiriou, C.⁵ Andre, F.⁶ Holmes, F.A.⁷ Valero, V.⁸ Booser, D.⁹ Pippen Jr., J.E.¹⁰ Vukelja, S.¹¹ Gomez, H.¹² Mejia, J.¹³ Barajas, L.J.¹⁴ Hess, K.R.¹⁵ Sneige, N.¹⁶ Hortobagyi, G.N.¹⁷ Pusztai, L.¹⁸ Symmans, W.F.¹⁹

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.